Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - valaciclovir hydrochloride - oral tablet - 500mg

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - valaciclovir hydrochloride - oral tablet - 500mg

Irland - Englisch - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - valaciclovir - film-coated tablet - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valaciclovir

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - valaciclovir hydrochloride 305,85 mg - eq. valaciclovir 250 mg - film-coated tablet - 250 mg - valaciclovir hydrochloride 305.85 mg - valaciclovir

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - valaciclovir hydrochloride 1223,4 mg - eq. valaciclovir 1000 mg - film-coated tablet - 1000 mg - valaciclovir hydrochloride 1223.4 mg - valaciclovir

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - valaciclovir hydrochloride 611,7 mg - eq. valaciclovir 500 mg - film-coated tablet - 500 mg - valaciclovir hydrochloride 611.7 mg - valaciclovir

Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - valaciclovir hydrochloride 556,28 mg - eq. valaciclovir 500 mg - film-coated tablet - 500 mg - valaciclovir hydrochloride 556.28 mg - valaciclovir

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

actavis pty ltd - valaciclovir hydrochloride; valaciclovir; valaciclovir (as hydrochloride) -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 556 mg (equivalent: valaciclovir, qty 500 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with zelitrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - valaciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; povidone; indigo carmine aluminium lake; titanium dioxide; hypromellose; polysorbate 80; macrogol 6000; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. treatment of ophthalmic zoster. treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes in immunocompromised patients with creatinine clearance of > 15 ml/min. for the reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valaciclovir, it is recommended that patients use safer sex practices (see precautions). for prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.